Thrombotic microangiopathy in United States long-term dialysis patients. |
| |
Authors: | Robert M Perkins Joel C Reynolds Tejinder S Ahuja Thomas Reid Lawrence Y Agodoa Erin M Bohen Christina M Yuan Kevin C Abbott |
| |
Institution: | Nephrology Service, Walter Reed Army Medical Center, Washington, DC 20307-5001, and Uniformed Services University of the Health Sciences, Bethesda, MD, USA. robert.perkins@na.amedd.army.mil |
| |
Abstract: | BACKGROUND: The incidence, risk factors, recurrence rates and prognosis of thrombotic microangiopathy (TMA) among long-term dialysis patients in the United States have not been previously described in a national population. METHODS: 272 024 Medicare primary patients in the United States Renal Data System (USRDS) initiated on end-stage renal disease (ESRD) therapy between 1 April 1995 and 31 December 1999 with Medicare as primary payer were analysed in a retrospective cohort study of USRDS of TMA. Cox regression was used to calculate adjusted hazard ratios (AHR) for risk of TMA and risk of death after TMA. RESULTS: The incidence of TMA in the first year of dialysis was 0.5% overall. Among patients with renal failure due to haemolytic uraemic syndrome (HUS), the incidence of TMA was highest in the first year of dialysis (HUS, 11.3% first year, 4.5% per year thereafter), while among patients without HUS the incidence of TMA was much lower and more constant over time (0.3% per year). In Cox regression analysis, independent risk factors for TMA were renal failure due to HUS (adjusted hazard ratio (AHR) 179, 95% CI 95-338), paediatric age (
|
| |
Keywords: | dialysis haemolytic uraemic syndrome (HUS) systemic lupus erythematosus thrombotic thrombocytopenic purpura (TTP) thrombotic microangiopathy United States Renal Data System (USRDS) |
本文献已被 Oxford 等数据库收录! |
|